Abiopharma

🔍 Moore Alexander D. (Director)

Company: Palantir Technologies Inc. (PLTR)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 3,516 shares of Class A Common Stock at $173.2121 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,091,579.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,520 shares of Class A Common Stock at $174.0721 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,084,059.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,455 shares of Class A Common Stock at $175.1319 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,080,604.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,509 shares of Class A Common Stock at $175.8424 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,079,095.00 | transaction_form_type: 4 | Footnotes: F1, F5

Footnotes:

• F1: The Reporting Person sold shares of Class A Common Stock in the open market pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on December 11, 2025.
• F2: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $172.64 to $173.6364. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (5) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $173.64 to $174.635. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (5) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $174.671 to $175.6581. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (5) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $175.7003 to $176.1361. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (5) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• REMARKS: This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person. For additional details regarding the Reporting Person's overall stock and equity holdings, please see the Issuer's Proxy Statement filed with the Securities and Exchange Commission on April 24, 2026, including under the heading "Security Ownership Of Certain Beneficial Owners And Management" (subject to the definitions, explanations, and time periods described therein).